Standout Papers

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Res... 2007 2026 2013 2019 1.7k
  1. Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer (2007)
    Helmut Oettle, Stefan Post et al. JAMA

Immediate Impact

1 by Nobel laureates 13 from Science/Nature 116 standout
Sub-graph 1 of 20

Citing Papers

TGF-β signaling in health and disease
2023 Standout
Pancreatic cancer: Advances and challenges
2023 Standout
15 intermediate papers

Works of H Schramm being referenced

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
A randomised, prospective, multicenter, phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resected pancreatic cancer
2005

Author Peers

Author Last Decade Papers Cites
H Schramm 1040 2114 768 42 2.4k
Eran Sadot 1188 1725 798 70 2.7k
Linus Ho 1461 1983 1473 57 3.0k
Osamu Kainuma 964 1549 768 79 2.0k
H. G. Beger 1037 1846 606 56 2.6k
Cornelius J. McGinn 705 1558 1472 38 3.2k
Neda Rezaee 925 1579 527 37 1.9k
John C. Mansour 1199 2074 1108 104 3.3k
Takeshi Iwanaga 958 1108 837 66 2.3k
Markus Wagner 2170 2336 1058 56 3.4k
Marc E. Delclos 1998 2464 1381 82 3.5k

All Works

Loading papers...

Rankless by CCL
2026